The U.S. Food and Drug Administration has approved Galderma's Nemluvio (nemolizumab) for the treatment of moderate-to-severe atopic dermatitis in patients aged 12 years and older.
a discovery that could offer new approaches to treating psychiatric conditions like anxiety and depression. In a recent study published in Science Advances and led by researchers from Northwestern ...
For the first time, NICE has recommended an innovative new treatment to help stop babies, children and young people who are undergoing cancer treatment from losing their hearing. We’ve issued final ...
Kadambi noted that older patients on fixed incomes are particularly affected by financial ... challenges with prior authorizations for cancer care and the frustration of making treatment decisions ...
High-functioning anxiety can have a negative impact on work, relationships, and someone's overall mental health. There are many ways to treat the condition, however, ranging from therapy and exercise ...